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280.2233.7, P>0.05) were found between the two groups, while LF/HF ratio was
signiﬁcantly higher in glucose ﬂuctuation patients than in non-glucose ﬂuctuation
subjects (2.70.4 vs 2.00.5, P<0.01). Negative correlations of MAGE with
SDNN, SDANN, and HF (r ¼ -0.611, -0.601, -0.542, respectively, P<0.05)
were found in diabetics, while MAGE was positive correlated with LF/HF ratio
(r ¼ 0.594, P<0.05).
Conclusions: Blood glucose variability could lower the HRV of the patients with
T2DM, which relates to impairing the cardiac autonomic nerve function and con-
tributes to the risk of CAD among individuals with diabetes.GW25-e0866
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Objectives: To investigate the effect of experimental acupuncture-meridian treatment
for patients with impaired glucose regulation.
Methods: We selected 59 patients with impaired glucose regulation. There are 31
patients in control group with general advices only but without positive interventions.
There are 28 patients in group of experimental acupuncture-meridian treatment one
month. This group includes three sub-groups: Zusanli (ST36) group, Zusanli (ST36) +
Shousanli (LI10) group, Zusanli (ST36) + Sanyinjiao (SP6) group. We measure and
compare blood pressure, body weight, body mass index (BMI), waist - height ratio
(WSR), OGTT (0 minute, 30 minutes, 60 minutes, 120 minutes, 180 minutes), the
average glucose, area under the curve of blood glucose (AUCg), glycosylated he-
moglobin (HbA1c), area under the curve of insulin (AUCI) and insulin resistance
index (HOMA-IR), IS index (Matsuda index), beta cell function index (OI30/
OG30 IR, MBCI, I phase Stumvoll index) between groups.
Results: The values before treatment of Zusanli (ST36) + Sanyinjiao (SP6) group are
OGTT (60 minutes) 11.020.83mmol/L, OGTT (120 minutes) 9.060.85 mmol/L,
the average glucose 8.100.62 mmol/L, and AUCg 26.281.89 mmol/L.h. The
values after the experimental acupuncture-meridian treatment for one month in
Zusanli (ST36) + Sanyinjiao (SP6) group are OGTT (60 minutes) 9.771.01 mmol/
L,OGTT (120min) 6.981.85 mmol/L, the average glucose 7.320.94 mmol/L, and
AUCg 22.923.32 mmol/L.h, which has declined with signiﬁcant differences than the
values before treatment (P<0.05). It also declines with signiﬁcant differences
compared with other three groups of patients (P<0.05).
Conclusions: In the experimental acupuncture-meridian treatment for patients with
impaired glucose regulation, Zusanli (ST36) + Sanyinjiao (SP6) is signiﬁcantly
effective for management of postprandial hyperglycemia. It is important to the delay
the onset of type 2 diabetes and reduces the occurrence of cardiovascular events, and
prevents the occurrence of serious diabetic microvascular complications.GW25-e1581
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Objectives: The present study aimed to identify the relationship between blood
glucose variability and the 10-year cardiovascular disease (CVD) risk in patients with
type 2 diabetes mellitus (T2DM).
Methods: A set of 68 consecutive T2DM patients without history of CVD were
included to assess blood glucose variability using mean amplitude of glycemic ex-
cursions (MAGE), which was obtained by continuous glucose monitoring system
(CGMS). Then patients were divided into two groups: subjects with non-glucose
ﬂuctuation (MAGE<3.9mmol/l, n¼32) and subjects with glucose ﬂuctuation
(MAGE>¼3.9mmol/l, n¼36). The 10-year cardiovascular disease (CVD) risks were
calculated by the general Framingham Risk Score and compared between two groups.
Correlation analysis of MAGE and the CVD risk was also performed.
Results: The mean T2DM duration was 3.6 years, without signiﬁcant difference
between two groups. The average Framingham Risk Score was 26.42% (Ranged
from 13.77% to 39.65%) in subjects with non-glucose ﬂuctuation, versus 38.64%
(Ranged from 17.02% to 63.92%) in patients with glucose ﬂuctuation (P<0.05).
The proportion of high CVD risk (Framingham Risk Score >20%) was 51.3% in
subjects with non-glucose ﬂuctuation, while it was as high as 72.5% in patients
with glucose ﬂuctuation (P<0.05). Correlation analysis showed that MAGE was
positive correlated with the 10-year CVD risk in T2DM patients (r ¼ 0.543,
P<0.05).
Conclusions: Blood glucose ﬂuctuation contributes to the the development of CVD in
individuals with type 2 diabetes mellitus.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/EGW25-e3148
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Objectives: Glycosylated hemoglobin (HbA1c) has become a key component of new
American Diabetes Association (ADA) diagnostic criteria for diabetes, which is not
included in the World Health Organization (WHO) 1999 criteria. Thus, we aimed to
compare WHO 1999 and new ADA diagnostic criteria for diabetes in Chinese non-
acute coronary syndrome (ACS) patients.
Methods: Non-ACS patients who had undergone elective coronary angiography
(CAG) in PUMCH without previously known diabetes were enrolled consecutively
from October 2013 to April 2014. Glucose metabolism abnormalities were evaluated
by fasting plasma glucose (FPG), 2-hour oral glucose tolerance test (2h-OGTT), and
HbA1c level before CAG. WHO recommended FPG7.0mmol/L and/or 2h-OGTT
glucose11.1mmol/L as the diagnostic criteria for diabetes, while ADA recom-
mended HbA1c6.5% as an additional diagnostic criterion.
Results: One hundred and thirty-nine patients (male: 88/139, 63.3%; age: [61.910.1]
years) were included. According to WHO 1999 criteria, 34 patients (24.4%) had
normal glucose regulation, 1 (0.7%) had impaired fasting glucose, 56 (40.3%) had
impaired glucose tolerance and 48 (34.5%) had newly diagnosed type 2 diabetes
mellitus (T2DM). ADA criteria diagnosed 8 more patients with T2DM than WHO
criteria, and those 8 patients had a higher female proportion (75% vs 31.3%,
P¼0.018), lower hemoglobin and hematocrit level [(124.8817.74) g/L vs
(140.1515.17) g/L, P¼0.013, (37.194.30) % vs (40.904.05) %, P¼0.021] as
well as a higher ﬁbrinogen level [(3.470.41) g/L vs (3.020.68) g/L, P¼0.024],
when compared with those diagnosed by both criteria.
Conclusions: Non-ACS patients who were admitted for elective CAG had a high
incidence of abnormal glucose metabolism. Compared with WHO 1999 criteria, new
ADA criteria with HbA1c assessment are able to identify more previously unknown
diabetes patients. Thus, HbA1c level may need to be measured routinely for screening
diabetes in patients undergoing elective CAG, especially for female patients with
lower hemoglobin level and higher ﬁbrinogen level.
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Objectives: An emerging term “Visceral Adiposity Index (VAI)” was reported to be
strongly correlated with glycaemic disturbances and diabetes risk, while little infor-
mation is known whether VAI could predict future type 2 diabetes mellitus (DM).
This study aims to assess the predictive value of VAI for DM in general Chinese
population.
Methods: This prospective cohort study was conducted based on a 15-year follow up
in a general Chinese population from an urban community. 711 subjects received
health examination in 1992, and in 2007 the same examination was performed for
them again. 24 were excluded from analysis since DM was diagnosed at baseline.
Waist circumference (WC), body mass index (BMI), VAI and cardiovascular risk
factors were collected at baseline.
Results: 74 individuals developed into DM during a follow up of 15 years. Risks of
future DM increased with increasing levels of VAI. Compared with the lowest
quartile, the highest quartiles of the 3 measures could statistically increase the risk for
the new onset of diabetes (HR¼2.90, 4.48 and 3.31 for BMI, WC and VAI respec-
tively). However, no statistic difference was found between the discriminatory power
of them (AUC¼0.668, 0.701 and 0.649 for BMI, WC and VAI respectively.)
Conclusions: VAI could predict independently in Chinese population, while the
predictive power is not better than that of simple anthropometric measures (BMI and
WC). Our study does not support the clinical application of VAI, and more studies
based on different races are needed to be performed.
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Objectives: To examine whether pluses pressure (PP) could predict diabetes idcidence
in a Chinese population during a 15-year follow-up.
Methods: The data were collected in 1992 and then again in 2007 from the same
group of 687 individuals. Questionnaire, physical examination and laboratory tests
were performance by a standard protocol. To assess the effects of baseline PP on
the new onset of diabetes, Cox’s proportional hazards regression models were used
to estimate the hazard ratios, and the discriminatory power of anthropometric
measures for diabetes was assessed by the area under the receiver operating curve
(ROC).pidemiology, Prevention and Control C113
